Browse Blood coagulation factors topic

Subtopics (17)

Articles

1-45 out of 45 article(s)

Title	Author	Type	Date	Words
Hemostasis test compatibility with capped and uncapped tubes.	Finnegan, Kathleen; Cutsforth, Gwyn	Report	Sep 22, 2011	2325
Stop that clot: haemostasis and anticoagulation: this is the first in a series of clinical articles Kai Tiaki Nursing New Zealand is publishing to provide a convenient way for nurses to earn continuing professional development hours.	Casey, Georgina	Report	Feb 1, 2011	4569
Off-label use of clotting factor ups embolism risk.		Report	Nov 16, 2010	458
Acquired hemophilia: a clinical experience.	Mirza, Muhammad A.; Khimani, Farhad; Rogers, John	Case study	Nov 1, 2010	2582
Direct-to-consumer genetic tests and the right to know.	Sandroff, Ronni	Report	Sep 1, 2010	1542
Recombinant factor VIIa and the patient with neurologic bleeding: separating fact from fiction.	Criddle, Laura M.	Report	Aug 1, 2010	4809
Downregulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 by grape seed proanthocyanidin extract.	Sandra, Dhungana; Radha, Madhyastha; Harishkumar, Madhyastha; Yuichi, Nakajima; Sayuri, Omura; Masug	Report	Jan 1, 2010	3330
Thrombophilia.	Levy, Howard P.		Apr 1, 2009	566
Inherited bleeding disorders: a 14-year retrospective study.	Eid, Suhair S.; Kamal, Nazmi R.; Shubeilat, Taisir S.; Wael, Abu-Ghoush Mohammed	Report	Sep 22, 2008	3372
Routine Factor V Leiden testing discouraged.	MacNeil, Jane Salodof	Clinical report	Apr 1, 2008	675
Factor V 1691 G-A mutation distribution in a healthy Turkish population/Saglikli Turk populasyonunda faktor V (1691 G-A) mutasyon sikligi.	Akar, Nejat	Report	Mar 1, 2008	2044
Combined heterozygote factor V Leiden mutation and anticardiolipin antibody positivity in a young patient with spontaneous deep vein thrombosis/Kombine heterozigot faktor V Leiden mutasyonu ve antikardiyolipin antikor pozitifligi olan genc bir hastada derin ven trombozu.	Karadurmus, Nuri; Ozturk, Cengiz; Sonmez, Alper; Dogru, Teoman; Inal, Satilmis; Tasci, Canturk; Oztu	Case study	Feb 1, 2008	1269
GTC Biotherapeutics Obtains Licenses to Factor IX, Factor VIII and Fibrinogen.			Dec 5, 2007	801
Detailed technical analysis of urine RNA-based tumor diagnostics reveals ETS2/Urokinase plasminogen activator to be a novel marker for bladder cancer.	Hanke, Merle; Kausch, Ingo; Dahmen, Gerlinde; Jocham, Dieter; Warnecke, Jens M.		Dec 1, 2007	5430
The effects of acidosis and hypothermia on blood transfusion requirements following factor VII administration.	Hall, K.; Forrest, P.; Sawyer, C.	Clinical report	Aug 1, 2007	2153
Don't cut dairy foods out of diet.			May 15, 2007	212
Why Bush wants TPA extended: President Bush wants Trade Promotion Authority for the sake of "free trade," but there is a growing grass-roots resistance to the harmful consequences of his trade agenda.	Capo, Jim		May 14, 2007	1814
ThromboGenics Announces Progress With its Pre-Clinical and Clinical Programs.			May 2, 2007	847
Vitamin D deficiency in the southern United States.	Tangpricha, Vin		Apr 1, 2007	1528
Zinc and calcium stearates provide lubricity.			Mar 22, 2007	205
Case report of an acquired factor XIII inhibitor: diagnosis and management.	Gregory, Thomas F.; Cooper, Barry	Clinical report	Jul 1, 2006	2432
Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum.	Piironen, Timo; Haese, Alexander; Huland, Hartwig; Steuber, Thomas; Christensen, Ib Jarle; Brunner,		May 1, 2006	5412
Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII: considerations on the differentiation between the 2 circulating anticoagulants.	Tripodi, Armando; Mancuso, Maria Elisa; Chantarangkul, Veena; Clerici, Marigrazia; Bader, Rossella;		Oct 1, 2005	2539
Poor agreement among prothrombin time International Normalized Ratio methods: comparison of seven commercial reagents.	Horsti, Juha; Uppa, Helena; Vilpo, Juhani A.		Mar 1, 2005	4308
Effect of specimen collection on routine coagulation assays and D-dimer measurement.	Lippi, Giuseppe; Guidi, Gian Cesare		Nov 1, 2004	1286
Clotting factor cuts volume of intracerebral bleeding.	Peck, Peggy		Sep 15, 2004	573
Factors influencing pre-eclampsia/eclampsia outcomes in high-risk patients in Zimbabwe.	Mudokwenuy-Rawdon, C.; Bezuidenhout, M.C.; Ehlers, V.J.		Mar 1, 2003	10498
Clot promoter cuts surgical bleeding. (Biomedicine).		Brief Article	Feb 1, 2003	214
Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer.	Castello, Remedios; Estelles, Amparo; Vazquez, Carlos; Falco, Cristina; Espana, Francisco; Almenar,		Aug 1, 2002	5185
Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm. (Original Articles).	Van Cott, Elizabeth M.; Soderberg, Britt L.; Laposata, Michael		May 1, 2002	5064
Evaluation of the TAS analyzer and the Low-Range Heparin Management Test in patients undergoing extracorporeal membrane oxygenation.	Ambrose, Theresa M.; Parvin, Curtis A.; Mendeloff, Eric; Luchtman-Jones, Lori	Clinical report	May 1, 2001	4613
Agreement of Owren and quick prothrombin times: effects of citrate and calcium concentrations and international sensitivity index correction.	Horsti, Juha		May 1, 2001	3532
Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests.	Dufour, D. Robert; Lott, John A.; Nolte, Frederick S.; Gretch, David R.; Koff, Raymond S.; Seeff, Le	Clinical report	Dec 1, 2000	18638
Coagulation and bleeding disorders: review and update.	Triplett, Douglas A.		Aug 1, 2000	6946
Coagulation factor XI boosts clot risk.	N.S.	Brief Article	Mar 25, 2000	266
Activated protein C resistance: automated detection of the factor V leiden mutation by mismatch hybridization.	Klingler, Karl R.; Junold, Thomas; Wielckens, Klaus		Nov 1, 1999	3933
Rapid, homogeneous genotyping of the 4G/5G polymorphism in the promoter region of the PAI1 gene by fluorescence resonance energy transfer and probe melting curves.	Nauck, Markus; Wieland, Heinrich; Marz, Winfred		Aug 1, 1999	4677
Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes.	Fareed, Jawed; Hoppensteadt, Debra A.; Leya, Fred; Iqbal, Omer; Wolf, Helmut; Bick, Roger		Aug 1, 1998	6272
Urokinase plasminogen activator: a prognostic marker in breast cancer including patients with axillary node-negative disease.	Duffy, Michael J.; Duggan, Catherine; Mulcahy, Hugh E.; McDermott, Enda W.; O'Higgins, Niall J.		Jun 1, 1998	3773
Combined use of markers of muscle necrosis and fibrinogen conversion in the early differentiation of myocardial infarction and unstable angina.	Hermens, Wim T.; Pelsers, Maurice M.A.L.; Mullers-Boumans, Marie-Louise; de Zwaan, Chris; Glatz, Jan	Letter to the editor	Apr 1, 1998	1355
Rebound increase of plasminogen activator inhibitor type I after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used.	Genser, Norbert; Lechleitner, Peter; Maier, Josef; Dienstl, Franz; Artner-Dworzak, Erika; Puschendor		Feb 1, 1998	3485
ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients.	Stephens, Ross W.; Pedersen, Anders N.; Nielsen, Hans Jorgen; Hamers, Maria J.A.G.; Hoyer-Hansen, Gu	Clinical report	Oct 1, 1997	5958
Summary evaluation of the Sysmex CA-6000 coagulation analyzer.	Gosselin, Robert C.; Owings, John T.; Larkin, Edward; Cannon, Janis		Sep 1, 1997	1389
Hemophiliac class rejects settlement offer.	Brienza, Julie		Nov 1, 1994	644
Blood clot agent's genes are read.			Aug 15, 1987	364